Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Psychopharmacology: underuse of evidence-based treatments in psychiatry.

Literature DB >> 14600298

Psychopharmacology: underuse of evidence-based treatments in psychiatry.

Mohamed Fayek¹, Calvin Flowers, Darin Signorelli, George Simpson.

Abstract

Mesh：

Substances：

Year: 2003 PMID： 14600298 DOI： 10.1176/appi.ps.54.11.1453

Source DB: PubMed Journal: Psychiatr Serv ISSN： 1075-2730 Impact factor: 3.084

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Emerging empirical evidence on the ethics of schizophrenia research.

Authors: Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal: Schizophr Bull Date: 2005-10-19 Impact factor: 9.306

2. Clozapine underutilization and discontinuation in African Americans due to leucopenia.

Authors: Deanna L Kelly; Julie Kreyenbuhl; Lisa Dixon; Raymond C Love; Deborah Medoff; Robert R Conley
Journal: Schizophr Bull Date: 2006-12-14 Impact factor: 9.306

3. The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia.

Authors: Marcela Horvitz-Lennon; Margarita Alegría; Sharon-Lise T Normand
Journal: Psychiatr Serv Date: 2012-12 Impact factor: 3.084

4. A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario.

Authors: Jisha M Lucca; Fatima M Al-Turaifi; Al-Mubayedh Safyah; Feras A Hamad Al-Awad
Journal: Psychopharmacol Bull Date: 2021-11-03

Review 5. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors: Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal: Schizophr Bull Date: 2009-12-02 Impact factor: 9.306

Psychopharmacology: underuse of evidence-based treatments in psychiatry.

Review 1. Emerging empirical evidence on the ethics of schizophrenia research.

2. Clozapine underutilization and discontinuation in African Americans due to leucopenia.

3. The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia.

4. A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario.

Review 5. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

6. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.

7. Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone.

8. Current status of clozapine in the United States.

9. Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management.

10. Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia.